<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03141606</url>
  </required_header>
  <id_info>
    <org_study_id>20140002277</org_study_id>
    <nct_id>NCT03141606</nct_id>
  </id_info>
  <brief_title>Left Atrial Volume as Predictor for Arrhythmic Events and CRT Response</brief_title>
  <acronym>iLAV</acronym>
  <official_title>Left Atrial Volume as Predictor for Arrhythmic Events and CRT Response</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale Borgo Trento - Verona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale Borgo Trento - Verona</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Left atrial volume role for CRT response and for arrhythmic events (VT/VF/AT/AF) onset
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2016</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>24 Months</target_duration>
  <primary_outcome>
    <measure>Cardiac remodelling</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluation of function and volume of left atrium (by means of echocardiographic measures) in terms of cardiac remodelling (at least 15% reduction in LVESV).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CRT Predictor Index</measure>
    <time_frame>6 months</time_frame>
    <description>Identification of left atrial index predicting CRT response</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical benefit</measure>
    <time_frame>12 months</time_frame>
    <description>Left atrial volume/function in terms of clinical benefit
Clinical Composite Score evaluation
QoL evaluation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac remodelling</measure>
    <time_frame>6 months</time_frame>
    <description>Left atrial volume/function in terms of cardiac remodelling
LVEF
LVESV/LVEF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Atrial arrhythmias</measure>
    <time_frame>24 months</time_frame>
    <description>Left atrial volume/function role in terms of:
atrial arrhythmias onset
Atrial arrhythmias burden</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventricular arrhythmias</measure>
    <time_frame>24 months</time_frame>
    <description>Left atrial volume/function in terms of:
ventricular arrhythmias onset
ventricular arrhythmias burden</description>
  </secondary_outcome>
  <enrollment type="Anticipated">230</enrollment>
  <condition>Left Atrial Volume</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients implanted with cardiac resynchronization therapy defirbillator devices and who
        meet the inclusion and exclusion criteria
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with left ventricular ejection fraction â‰¤ 35%, II, III or IV NYHA Class, even
             if optimal medical therapy.

          -  Patients with standard indication to CRT according current guideline, sinus rhythm at
             implantation, LBBB and QRS duration &gt;= 120 ms

          -  Patients who will undergo to a new CRT-defibrillator system implantation

          -  Patients who are able to understand and sign the informed consent

          -  Patients who are able to attend all required follow-up visits at the study centerfor
             24 months

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Women who are pregnant or who are planning to become pregnant

          -  Patients with permanent Atrial Fibrillation or persistent Atrial Fibrillation in the
             90 days preceding the implantation

          -  Patients with organic mitral valve disease

          -  Patients with prosthetic heart valves

          -  Patients who will undergo to upgrading from other devices (PM or ICD) to CRT, heart
             transplantation, patients with CRT devices
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>G. Panico Hospital</name>
      <address>
        <city>Tricase</city>
        <state>Italy/Lecce</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pietro Palmisano</last_name>
      <email>clinical-rhythmdetect@isis.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Borgo Trento Hospital</name>
      <address>
        <city>Verona</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Morani</last_name>
      <phone>045 812 1111</phone>
      <email>giovanni.morani@ospedaleuniverona.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2017</study_first_submitted>
  <study_first_submitted_qc>May 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2017</study_first_posted>
  <last_update_submitted>May 2, 2017</last_update_submitted>
  <last_update_submitted_qc>May 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale Borgo Trento - Verona</investigator_affiliation>
    <investigator_full_name>Dr. Giovanni Morani</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

